NDC 0220-6517

Colibacillinum

Escherichia Coli

Colibacillinum is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Boiron. The primary component is Escherichia Coli.

Product ID0220-6517_85411aca-0ef2-9d48-e053-2991aa0a0790
NDC0220-6517
Product TypeHuman Prescription Drug
Proprietary NameColibacillinum
Generic NameEscherichia Coli
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBoiron
Substance NameESCHERICHIA COLI
Active Ingredient Strength15 [hp_C]/15[hp_C]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0220-6517-41

15 [hp_C] in 1 TUBE (0220-6517-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-6517-41 [00220651741]

Colibacillinum PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
ESCHERICHIA COLI15 [hp_C]/15[hp_C]

OpenFDA Data

SPL SET ID:85411aca-0ef1-9d48-e053-2991aa0a0790
Manufacturer
UNII

NDC Crossover Matching brand name "Colibacillinum" or generic name "Escherichia Coli"

NDCBrand NameGeneric Name
0220-6515ColibacillinumESCHERICHIA COLI
0220-6517ColibacillinumESCHERICHIA COLI
68428-920Colibacillinum cum natrum muriaticumESCHERICHIA COLI
71919-219Colibacillinum cum natrum muriaticumESCHERICHIA COLI
60681-1224Pleo San Coliescherichia coli
60681-1225Pleo San Coliescherichia coli

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.